Request Sample
Request Methodology
Description
Self-Monitoring Blood Glucose Devices Market size was valued at USD 12.82 billion in 2021. It is expected to reach a value of USD 22.84 billion by 2028, at a CAGR of 8.6% from 2022-2028. Self-monitoring blood glucose technology methods are small, portable devices that can detect disease risk. These instruments often take a tiny blood sample from patients by pricking their fingertips in order to measure their blood sugar levels. This approach is advised by international recommendations for effectively managing diabetes in patients. The blood glucose concentration is measured using a self-monitoring blood glucose monitor. The COVID-19 pandemic had a favourable effect on the expansion of the self-monitoring blood glucose market. Diabetes problems, aberrant glucose variability, and increased blood glucose levels may be experienced by COVID-19-infected patients who have diabetes. The COVID-19 emergency has highlighted the significance of self-monitoring blood glucose devices, therefore it is important to keep an eye on a patient’s blood glucose monitoring to prevent aggravation. Going forward, it is anticipated that the market for self-monitoring blood glucose devices would expand due to the increased prevalence of diabetes. Self-monitoring of blood glucose is a technique whereby a person with diabetes uses a glycemic reading device to measure their blood sugar (glucose metre) so that they can adjust or monitor the effectiveness of their treatment (diet, exercise, insulin, antidiabetics), or see their doctor, based on the test results.
